ÖWÖrjan Wrange

Örjan Wrange

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Örjan Wrange has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Birgitta Gelius

    Department of Cell and Molecular Biology, The Medical Nobel Institute, Box 285, Karolinska Institutet, SE-17177 Stockholm, Sweden and 2W.A.Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 117984, Russia 3Corresponding author

    4 shared publications
  • Sergey Belikov

    Department of Cell and Molecular Biology, The Medical Nobel Institute, Karolinska Institutet, SE-17177 Stockholm, Sweden

    4 shared publications
  • Lars Wieslander

    Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-106 91 Stockholm, Sweden

    2 shared publications
  • Patrik Blomquist

    Laboratory of Molecular Genetics, Department of Cell and Molecular Biology, Medical Nobel Institute,Karolinska Institute, S-171 77 Stockholm, Sweden

    2 shared publications
  • Alan Wolffe

    Laboratory of Molecular Embryology, National Institute of Child Health and Human Development, Bethesda, USA

    1 shared publication
  • Ann-Kristin Östlund Farrants

    Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institute, Stockholm, Sweden

    1 shared publication

Latest Publications

  • Open Access

    Chromatin-Mediated Restriction of Nuclear Factor 1/CTF Binding in a Repressed and Hormone-Activated Promoter In Vivo

    by Sergey Belikov, Carolina Åstrand, Per-Henrik Holmqvist, Örjan Wrange

    Mouse mammary tumor virus (MMTV) promoter-driven transcription is induced by glucocorticoid hormone via binding of the glucocorticoid receptor (GR). The MMTV promoter also harbors a binding site for nuclear factor 1 (NF1). NF1 and GR were expressed in Xenopus oocytes; this revealed GR-NF1 cooperativity both in terms of DNA binding and chromatin remodeling but not transcription. A fraction of NF1 sites were occupied in a hormone-dependent fashion, but a significant and NF1 concentration-dependent fraction were constitutively bound. Activation of the MMTV promoter resulted in an ∼50-fold increase in the NF1 accessibility for its DNA site. The hormone-dependent component of NF1 binding was dissociated by addition of a GR antagonist; however, the antagonist RU486, which supports partial GR-DNA binding, also maintained partial NF1 binding. Hence GR-NF1 cooperativity is independent of agonist-driven chromatin remodeling. NF1 induced the formation of a micrococcal-nuclease-resistant protein-DNA complex containing the DNA segment from −185 to −55, the MMTV enhanceosome. Coexpression of NF1 and Oct1 resulted in a significant stimulation of hormone-induced MMTV transcription and also in increased basal transcription. We propose that hormone-independent NF1 binding may be involved in maintaining transcriptional competence and establishment of tissue-specific gene networks.


    • 14 November 2002
      • Vol. 99  (46) , 4665-7

    [The scientific committee's task is to identify the best research].

    by Orjan Wrange, Lars Wieslander

    • 31 October 2002
      • Vol. 99  (44) , 4392-8

    [Advice to the Scientific Committee: There is only one way to distribute basic research grants].

    by Orjan Wrange, Lars Wieslander

  • Open Access

    Hormone‐induced nucleosome positioning in the MMTV promoter is reversible

    by Sergey Belikov, Birgitta Gelius, Örjan Wrange

    The mouse mammary tumor virus (MMTV) promoter is induced by glucocorticoid hormone via the glucocorticoid receptor (GR). The hormone‐triggered effects on MMTV transcription and chromatin structure were studied in Xenopus oocytes. We previously showed that the nucleosomes organizing the MMTV promoter became translationally positioned upon hormone induction. A single GR‐binding site was necessary and sufficient for the chromatin events to occur, while transcription and basal promoter elements were dispensable. Here we show that addition of the hormone antagonists RU486 or RU43044 to the previously hormone‐induced MMTV promoter results in cessation of transcription and loss of chromatin remodeling and nucleosome positioning. In vivo footprinting demonstrated agonist‐ and RU486‐induced GR binding to its DNA response element (GRE), while the other antagonist, RU43044, did not promote GR–GRE interaction. These results demonstrate that induction and maintenance of nucleosome positioning is an active process that requires constant ‘pressure’ of agonist–GR‐recruited chromatin‐modifying factor(s) rather than GR–DNA binding itself.


  • Open Access

    Hormone activation induces nucleosome positioning in vivo

    by Sergey Belikov, Birgitta Gelius, Geneviève Almouzni, Örjan Wrange

    The mouse mammary tumor virus (MMTV) promoter is induced by glucocorticoid hormone. A robust hormone‐ and receptor‐dependent activation could be reproduced in Xenopus laevis oocytes. The homogeneous response in this system allowed a detailed analysis of the transition in chromatin structure following hormone activation. This revealed two novel findings: hormone activation led to the establishment of specific translational positioning of nucleosomes despite the lack of significant positioning in the inactive state; and, in the active promoter, a subnucleosomal particle encompassing the glucocorticoid receptor (GR)‐binding region was detected. The presence of only a single GR‐binding site was sufficient for the structural transition to occur. Both basal promoter elements and ongoing transcription were dispensable. These data reveal a stepwise process in the transcriptional activation by glucocorticoid hormone.


  • Characterization of a chromatin remodelling activity in Xenopus oocytes

    by Birgitta Gelius, Paul Wade, Alan Wolffe, Örjan Wrange, Ann‐Kristin Östlund Farrants

    The yeast SWI2/SNF2 protein is a component of a large protein complex which is involved in the remodelling of chromatin during transcriptional activation. Several homologous complexes have been found in Drosophila and mammals. We have examined the expression of the SWI2/SNF2 homologue BRG1 in Xenopus laevis using two antisera originally raised against the C‐terminus of the rat and the human BRG1 protein. These two antisera cross‐reacted with a protein found in both Xenopus liver and Xenopus oocytes. The Xenopus BRG1‐like protein is expressed throughout oogenesis (stages I–VI) and embryogenesis. By injecting an expression vector containing the full‐length human BRG1 cDNA into Xenopus oocytes, the relative molecular weight (Mr) of the Xenopus BRG1‐like protein was shown to be slightly lower than that of the human BRG1, 190 000 and 200 000, respectively. The Xenopus BRG1‐like protein elutes at a Mr of ≈ 2 000 000 on Superose HR6™ size‐exclusion chromatography, indicating that it is part of a larger complex, as are all other known SWI/SNF proteins. Nucleosome remodelling activity was co‐eluted with the BRG1 immunogenic activity in both ion‐exchange and size‐exclusion chromatography.


  • Open Access

    Increased nuclear factor 1 binding to its nucleosomal site mediated by sequence-dependent DNA structure

    by Patrik Blomquist, Sergey Belikov, ÖRjan Wrange

    The organization of DNA into chromatin is important in the regulation of transcription, by influencing the access of transcription factors to their DNA binding sites. Nuclear factor 1 (NF-1) is a transcription factor which binds to DNA constitutively and which interacts with its cognate DNA site with high affinity. However, this affinity is drastically reduced, ∼100- to 300-fold, when the binding site is organized into a nucleosome. Here we demonstrate that the introduction of stretches of adenines of length 5 nt (A-tracts) on both sides of the NF-1 binding site has a distinct effect on NF-1 binding to a nucleosomal, but not to a free, NF-1 binding site. The position of the A-tracts, relative to the rotational phase of a synthetic DNA bending sequence, the TG-motif, decides whether the NF-1 affinity increases or decreases. The NF-1 binding affinity is seven times stronger when the flanking A-tracts are positioned out-of-phase with the TG-motif than it is when the A-tracts are positioned in-phase with the TG-motif. We demonstrate that this effect correlates with differences in DNA curvature and apparent histone octamer affinity. We conclude that DNA curvature influences the local histone-DNA contacts and hence the accessibility of the NF-1 site in a nucleosome context.


  • Open Access

    Glucocorticoid Receptor-Glucocorticoid Response Element Binding Stimulates Nucleosome Disruption by the SWI/SNF Complex

    by Ann-Kristin Östlund Farrants, Patrik Blomquist, Hyockman Kwon, Örjan Wrange

    The organization of DNA in chromatin is involved in repressing basal transcription of a number of inducible genes. Biochemically defined multiprotein complexes such as SWI/SNF (J. Côté, J. Quinn, J. L. Workman, and C. L. Peterson, Science 265:53-60, 1994) and nucleosome remodeling factor (T. Tsukiyama and C. Wu, Cell 83:1011-1020, 1995) disrupt nucleosomes in vitro and are thus candidates for complexes which cause chromatin decondensation during gene induction. In this study we show that the glucocorticoid receptor (GR), a hormone-inducible transcription factor, stimulates the nucleosome-disrupting activity of the SWI/SNF complex partially purified either from HeLa cells or from rat liver tissue. This GR-mediated stimulation of SWI/SNF nucleosome disruption depended on the presence of a glucocorticoid response element. The in vitro-reconstituted nucleosome probes used in these experiments harbored 95 bp of synthetic DNA-bending sequence in order to rotationally position the DNA. The GR-dependent stimulation of SWI/SNF-mediated nucleosome disruption, as evaluated by DNase I footprinting, was 2.7- to 3.8-fold for the human SWI/SNF complex and 2.5- to 3.2-fold for the rat SWI/SNF complex. When nuclear factor 1 (NF1) was used instead of GR, there was no stimulation of SWI/SNF activity in the presence of a mononucleosome containing an NF1 binding site. On the other hand, the SWI/SNF nucleosome disruption activity increased the access of NF1 for its nucleosomal binding site. No such effect was seen on binding of GR to its response element. Our results suggest that GR, but not NF1, is able to target the nucleosome-disrupting activity of the SWI/SNF complex.